Pharma Reaserch Prod Co Ltd (214450) — Tangible Net Worth Ratio
Pharma Reaserch Prod Co Ltd (214450) has a Tangible Net Worth Ratio of 97.4% as of December 2025. This metric is calculated by deducting intangible assets (₩18.99 Billion) from net assets (₩723.88 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore 214450 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Pharma Reaserch Prod Co Ltd Tangible Net Worth Ratio (2015–2025)
This chart shows how Pharma Reaserch Prod Co Ltd's Tangible Net Worth Ratio has changed across 11 annual periods from 2015 to 2025. As of December 2025, the ratio stands at 97.4%, reflecting net assets of ₩723.88 Billion with intangible assets of ₩18.99 Billion KRW. For live market cap and overall valuation, see how much is Pharma Reaserch Prod Co Ltd worth.
Annual Tangible Net Worth Ratio for Pharma Reaserch Prod Co Ltd (2015–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Pharma Reaserch Prod Co Ltd from 2015 to 2025, covering 11 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. Explore Pharma Reaserch Prod Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 97.4% | ₩723.88 Billion | ₩18.99 Billion | ₩1.04 Trillion | ▲ +0.8 pp |
| 2024 | 96.6% | ₩569.44 Billion | ₩19.54 Billion | ₩855.70 Billion | ▲ +1.0 pp |
| 2023 | 95.6% | ₩462.19 Billion | ₩20.32 Billion | ₩535.28 Billion | ▲ +2.6 pp |
| 2022 | 93.0% | ₩343.50 Billion | ₩24.02 Billion | ₩478.06 Billion | ▲ +1.5 pp |
| 2021 | 91.5% | ₩305.44 Billion | ₩26.02 Billion | ₩427.65 Billion | ▲ +2.4 pp |
| 2020 | 89.1% | ₩245.42 Billion | ₩26.81 Billion | ₩319.83 Billion | ▲ +3.3 pp |
| 2019 | 85.7% | ₩209.07 Billion | ₩29.81 Billion | ₩269.93 Billion | ▲ +1.9 pp |
| 2018 | 83.8% | ₩197.62 Billion | ₩31.98 Billion | ₩258.19 Billion | ▼ -14.9 pp |
| 2017 | 98.7% | ₩178.85 Billion | ₩2.28 Billion | ₩189.03 Billion | ▲ +0.1 pp |
| 2016 | 98.7% | ₩171.64 Billion | ₩2.29 Billion | ₩179.33 Billion | ▼ -0.3 pp |
| 2015 | 98.9% | ₩156.75 Billion | ₩1.65 Billion | ₩169.31 Billion | — |